U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06862219) titled 'A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer' on March 03.
Brief Summary: This study is for Indian adults in India who have cancer in the bladder lining (urothelial cancer). Their cancer is advanced or has spread to other parts of the body. Enfortumab vedotin is a treatment for this type of cancer.
The main aim of the study is to confirm the safety of enfortumab vedotin in Indian adults with urothelial cancer.
During the study, people will receive enfortumab vedotin. The study treatment will be given to people slowly through a tube into a vein. This is called an infusion. People will receive 3 separ...